Emerging from the UK, retatrutide, a novel peptide , is creating considerable interest within the healthcare community regarding its potential for weight regulation. This dual GIP and GLP-1 receptor agonist seems to offer a substantial advantage over existing therapies, showing encouraging results in early clinical studies . Researchers think it… Read More